Nutex Health (NUTX) Cost of Revenue (2010 - 2026)

Nutex Health has disclosed Cost of Revenue across 17 years of filings, most recently posting $4.0 million for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $4.0 million, up 5.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.4 million (up 26.77% YoY), and the FY2025 annual result was $17.2 million, up 12.8% from the prior year.
• Cost of Revenue came in at $4.0 million for Q1 2026 at Nutex Health, down from $5.3 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $5.3 million in Q1 2024 to a low of $2.4 million in Q4 2024.
• The 5-year median for Cost of Revenue is $3.6 million (2024), against an average of $3.7 million.
• Peak annual rise in Cost of Revenue reached 168.32% in 2022, while the deepest fall reached 49.7% in 2022.
• Nutex Health's Cost of Revenue stood at $2.8 million in 2022, then grew by 21.89% to $3.4 million in 2023, then retreated by 29.73% to $2.4 million in 2024, then soared by 122.54% to $5.3 million in 2025, then retreated by 24.66% to $4.0 million in 2026.
• The last three Cost of Revenue figures came in at $4.0 million (Q1 2026), $5.3 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.